The 'Switch’ study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug

Publication | Open Access

DOI Full Paper Access

Citations

References

2014

Year

Nuria C. Navarro Coy, Sarah Brown, Ailsa Bosworth, Claire Davies, Paul Emery, Colin Everett, Catherine Fernandez, Suzanne Hartley, Claire Hulme, Anne‐Maree Keenan,

BMC Musculoskeletal Disorders